NO20042393L - Polymorf av et farmakum - Google Patents

Polymorf av et farmakum

Info

Publication number
NO20042393L
NO20042393L NO20042393A NO20042393A NO20042393L NO 20042393 L NO20042393 L NO 20042393L NO 20042393 A NO20042393 A NO 20042393A NO 20042393 A NO20042393 A NO 20042393A NO 20042393 L NO20042393 L NO 20042393L
Authority
NO
Norway
Prior art keywords
polymorph
drug
Prior art date
Application number
NO20042393A
Other languages
English (en)
Other versions
NO327320B1 (no
Inventor
John F Bauer
Azita Saleki-Gerhardt
Bikshandarkoil A Narayanan
Sanjay Chemburkar
Ketan Patel
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26817251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20042393(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Publication of NO20042393L publication Critical patent/NO20042393L/no
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO327320B1 publication Critical patent/NO327320B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
NO20042393A 1998-07-20 2004-06-09 Polymorf av et farmakum NO327320B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11934598A 1998-07-20 1998-07-20
US32609399A 1999-06-04 1999-06-04
PCT/US1999/016334 WO2000004016A2 (en) 1998-07-20 1999-07-19 Polymorph of ritonavir

Publications (2)

Publication Number Publication Date
NO20042393L true NO20042393L (no) 2001-01-18
NO327320B1 NO327320B1 (no) 2009-06-08

Family

ID=26817251

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20010298A NO318385B1 (no) 1998-07-20 2001-01-18 Krystallinsk polymorf av (2S,3S,5S)-5-(N-(N-((N-metyl-N((2-isopropyl-4-tiazolyl)metyl)amino)karbonyl)-L-valinyl)-amino)-2-(N-((5-tiazolyl)metoksykarbonyl)amino)-1,6-difenyl-3-hydroksyheksan og fremgangsmateved dens fremstilling, samt farmasoytisk sammensetning inneholdende forbindelsen og anvendelse av forbindelsen.
NO20042393A NO327320B1 (no) 1998-07-20 2004-06-09 Polymorf av et farmakum

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20010298A NO318385B1 (no) 1998-07-20 2001-01-18 Krystallinsk polymorf av (2S,3S,5S)-5-(N-(N-((N-metyl-N((2-isopropyl-4-tiazolyl)metyl)amino)karbonyl)-L-valinyl)-amino)-2-(N-((5-tiazolyl)metoksykarbonyl)amino)-1,6-difenyl-3-hydroksyheksan og fremgangsmateved dens fremstilling, samt farmasoytisk sammensetning inneholdende forbindelsen og anvendelse av forbindelsen.

Country Status (30)

Country Link
EP (4) EP2017269B1 (no)
JP (4) JP4815050B2 (no)
KR (3) KR100853371B1 (no)
CN (5) CN1502613A (no)
AR (5) AR019431A1 (no)
AT (3) ATE534636T1 (no)
AU (1) AU768207B2 (no)
BG (4) BG65150B1 (no)
BR (1) BR9912010A (no)
CA (3) CA2337846C (no)
CO (1) CO5090830A1 (no)
CY (2) CY1111600T1 (no)
CZ (2) CZ298188B6 (no)
DE (2) DE69915628T2 (no)
DK (3) DK2017269T3 (no)
ES (3) ES2214038T3 (no)
HK (2) HK1037918A1 (no)
HU (3) HU227540B1 (no)
ID (1) ID27996A (no)
IL (4) IL140492A0 (no)
MY (2) MY145265A (no)
NO (2) NO318385B1 (no)
NZ (2) NZ522690A (no)
PL (2) PL213978B1 (no)
PT (3) PT1097148E (no)
SI (3) SI1418174T1 (no)
SK (3) SK286388B6 (no)
TR (1) TR200100171T2 (no)
TW (3) TWI362382B (no)
WO (1) WO2000004016A2 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
US6894171B1 (en) 1998-07-20 2005-05-17 Abbott Laboratories Polymorph of a pharmaceutical
ATE332132T1 (de) * 1999-06-04 2006-07-15 Abbott Lab Verbesserte arzneizubereitungen enthaltend ritonavir
WO2002096395A1 (en) * 2001-05-25 2002-12-05 Abbott Laboratories Soft elastic capsules comprising ritonavir and/or lopinavir
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
US7205413B2 (en) 2002-05-03 2007-04-17 Transform Pharmaceuticals, Inc. Solvates and polymorphs of ritonavir and methods of making and using the same
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
BRPI0401742B8 (pt) 2004-05-13 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda composto análogo do ritonavir útil como inibidor de protease retroviral, preparação do composto análogo do ritonavir e composição farmacêutica do composto análogo do ritonavir
WO2006129276A1 (en) * 2005-05-30 2006-12-07 Ranbaxy Laboratories Limited Processes for the preparation of stable polymorphic form i of ritonavir
EP2077903A2 (en) * 2006-10-03 2009-07-15 Ranbaxy Laboratories, Ltd. Process for the preparation of form i and form ii of ritonavir
CN102898398B (zh) * 2011-07-27 2015-01-14 上海迪赛诺药业有限公司 一种制备i型利托那韦多晶型结晶的方法
HUE027829T2 (en) 2012-03-07 2016-11-28 Ratiopharm Gmbh Dosage forms containing non-crystalline lopinavir and crystalline ritonavir
ES2587559T3 (es) 2012-03-07 2016-10-25 Ratiopharm Gmbh Forma farmacéutica que comprende lopinavir y ritonavir
MX2016002560A (es) 2013-08-29 2016-10-26 Teva Pharma Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
CA2942877A1 (en) 2014-04-08 2015-10-15 Nitzan SHAHAR Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
CN106749085B (zh) * 2016-12-23 2019-05-24 东北制药集团股份有限公司 一种制备利托那韦的方法
EP3569225A1 (en) 2018-05-18 2019-11-20 Pharmaceutical Oriented Services Ltd Solid dispersion containing ritonavir
RU2759544C1 (ru) * 2021-01-29 2021-11-15 Общество с ограниченной ответственностью "АМЕДАРТ" Твёрдая фармацевтическая композиция для изготовления перорального терапевтического средства для профилактики и/или лечения ВИЧ-инфекции

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5539122A (en) * 1989-05-23 1996-07-23 Abbott Laboratories Retroviral protease inhibiting compounds
US5354866A (en) 1989-05-23 1994-10-11 Abbott Laboratories Retroviral protease inhibiting compounds
DE69332616T2 (de) * 1992-12-29 2003-11-06 Abbott Laboratories, Abbott Park Hemmer der retroviralen Protease
IL110752A (en) 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en) * 1993-10-01 1996-09-24 Abbott Laboratories Pharmaceutical composition
US5491253A (en) 1993-10-22 1996-02-13 Abbott Laboratories Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
IL111991A (en) 1994-01-28 2000-07-26 Abbott Lab Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
US5567823A (en) * 1995-06-06 1996-10-22 Abbott Laboratories Process for the preparation of an HIV protease inhibiting compound
US6037157A (en) 1995-06-29 2000-03-14 Abbott Laboratories Method for improving pharmacokinetics
US6160122A (en) 1996-06-28 2000-12-12 Abbott Laboratories Process for the preparation of a disubstituted thiazole
ZA9710071B (en) 1996-11-21 1998-05-25 Abbott Lab Pharmaceutical composition.
MY145265A (en) * 1998-07-20 2012-01-13 Abbott Lab Amorphous ritonavir
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
ATE332132T1 (de) * 1999-06-04 2006-07-15 Abbott Lab Verbesserte arzneizubereitungen enthaltend ritonavir

Also Published As

Publication number Publication date
BG105197A (en) 2001-10-31
KR100853371B1 (ko) 2008-08-22
SI1097148T1 (en) 2004-10-31
NO20010298D0 (no) 2001-01-18
EP2298751A2 (en) 2011-03-23
EP1097148B1 (en) 2004-03-17
NO318385B1 (no) 2005-03-14
HUP0103823A2 (hu) 2002-02-28
ATE425974T1 (de) 2009-04-15
IL191582A (en) 2016-02-29
CA2510949C (en) 2009-11-17
JP2014074047A (ja) 2014-04-24
DE69940616D1 (de) 2009-04-30
HU229999B1 (en) 2015-04-28
WO2000004016A3 (en) 2000-03-30
EP1418174A2 (en) 2004-05-12
BG109682A (bg) 2007-03-30
CN1502613A (zh) 2004-06-09
CZ2001203A3 (en) 2001-05-16
JP2017061475A (ja) 2017-03-30
PL194710B1 (pl) 2007-06-29
DK2017269T3 (da) 2012-03-05
SI1418174T1 (sl) 2009-08-31
EP2298751A3 (en) 2011-08-17
JP2010270135A (ja) 2010-12-02
DK1097148T3 (da) 2004-04-26
BG66140B1 (bg) 2011-07-29
ES2214038T3 (es) 2004-09-01
IL191582A0 (en) 2008-12-29
AU5003799A (en) 2000-02-07
TWI227713B (en) 2005-02-11
EP2017269A2 (en) 2009-01-21
DK1418174T3 (da) 2009-05-18
CO5090830A1 (es) 2001-10-30
SK287381B6 (sk) 2010-08-09
CA2510949A1 (en) 2000-01-27
EP1418174A3 (en) 2004-06-23
KR20010072003A (ko) 2001-07-31
NZ522690A (en) 2004-04-30
MY145265A (en) 2012-01-13
AR059763A2 (es) 2008-04-30
MY121765A (en) 2006-02-28
BG65963B1 (bg) 2010-07-30
CY1111600T1 (el) 2015-10-07
HU0800267D0 (en) 2008-06-30
PL213978B1 (pl) 2013-05-31
IL140492A0 (en) 2002-02-10
CZ2006533A3 (cs) 2001-05-16
CY1112139T1 (el) 2015-11-04
AR019431A1 (es) 2002-02-20
JP2002520410A (ja) 2002-07-09
ES2322759T3 (es) 2009-06-26
ATE534636T1 (de) 2011-12-15
EP2017269A8 (en) 2009-09-30
ES2372990T3 (es) 2012-01-30
BG65150B1 (bg) 2007-04-30
KR20040081137A (ko) 2004-09-20
BG110080A (bg) 2008-11-28
EP2017269B1 (en) 2011-11-23
AU768207B2 (en) 2003-12-04
BR9912010A (pt) 2001-04-10
SK286388B6 (sk) 2008-09-05
DE69915628D1 (en) 2004-04-22
TR200100171T2 (tr) 2001-05-21
CZ298188B6 (cs) 2007-07-18
NO20010298L (no) 2001-01-18
CA2674800A1 (en) 2000-01-27
HK1121155A1 (en) 2009-04-17
KR100793046B1 (ko) 2008-01-10
CN101966180A (zh) 2011-02-09
ATE261947T1 (de) 2004-04-15
KR100740796B1 (ko) 2007-07-20
HUP0103823A3 (en) 2003-05-28
CA2337846C (en) 2006-02-21
PT1418174E (pt) 2009-06-08
KR20060118022A (ko) 2006-11-17
NO327320B1 (no) 2009-06-08
SK287586B6 (sk) 2011-03-04
PT1097148E (pt) 2004-05-31
TWI271400B (en) 2007-01-21
AR049658A2 (es) 2006-08-23
HK1037918A1 (en) 2002-02-22
AR044029A2 (es) 2005-08-24
IL187181A0 (en) 2008-02-09
CN1310715B (zh) 2010-11-03
IL140492A (en) 2010-12-30
JP5732212B2 (ja) 2015-06-10
HU230150B1 (hu) 2015-09-28
CA2337846A1 (en) 2000-01-27
WO2000004016A2 (en) 2000-01-27
AR059764A2 (es) 2008-04-30
HU0800266D0 (en) 2008-06-30
TW200716550A (en) 2007-05-01
PL348033A1 (en) 2002-05-06
EP1097148A2 (en) 2001-05-09
NZ509125A (en) 2003-02-28
CN102153524A (zh) 2011-08-17
CN101259128A (zh) 2008-09-10
EP2017269A9 (en) 2009-10-14
CN1310715A (zh) 2001-08-29
EP1418174B1 (en) 2009-03-18
SI2017269T1 (sl) 2012-02-29
EP2017269A3 (en) 2009-06-10
JP4815050B2 (ja) 2011-11-16
CZ307116B6 (cs) 2018-01-24
TWI362382B (en) 2012-04-21
DE69915628T2 (de) 2004-08-12
SK922001A3 (en) 2001-07-10
IL187181A (en) 2009-09-01
ID27996A (id) 2001-05-03
HU227540B1 (en) 2011-08-29
PT2017269E (pt) 2011-12-20

Similar Documents

Publication Publication Date Title
NO20042393L (no) Polymorf av et farmakum
NO973938L (no) Farmasöytisk preparat av piperidinoalkanolforbindelser
FI972292A0 (fi) Administrering av diabetes
PT984773E (pt) Formulacao farmaceutica a base de omeprazole
NO20011886L (no) Utforminger av fexofenadin
BR9610214A (pt) Compostos farmacéuticos
NO20020622L (no) Polymorfer av torsemid
NO20012976D0 (no) Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
NO20004288L (no) FremgangsmÕte til fremstilling av et beskyttet 4-aminometyl- pyrrolidin-3-on
NO20014926D0 (no) Farmasöytiske forbindelser
NO20021937L (no) Fremgangsmåte for administrering av en fosfodiesterase 4- hemmer
NO983666D0 (no) Krystallmodifikasjon av et farmasöytisk middel
ID24527A (id) Proses pembuatan senyawa-senyawa farmasi
ID28451A (id) Trisiklik piperidin-δ3 sebagai bahan farmasi
NO994027D0 (no) Polymorf av zopolrestat-monohydrat
ID24327A (id) Produksi senyawa-senyawa avermektin
NO20000811D0 (no) Fremgangsmåte for valg av medicament
FR2802852B3 (fr) Production d'elements figures
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
NO20014051D0 (no) Fremgangsmate for fremstilling av et noringsmiddel
EE200100084A (xx) NOS inhibiitorite uued farmatseutilised kasutusv�imalused
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
NO20004613D0 (no) FremgangsmÕte for fremstilling av et tetrapeptid
NO965448D0 (no) Farmasöytiske forbindelser
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin

Legal Events

Date Code Title Description
MK1K Patent expired